Prof. Stefan Chłopicki
Jagiellonian Centre for Experimental Therapeutics (JCET), Krakow, Poland
Stefan Chłopicki is a Professor of Pharmacology at Chair of Pharmacology at Jagiellonian University Medical College, and an initiator and Director of Jagiellonian Centre for Experimental Therapeutics (JCET), the newly-established interdisciplinary academic research centre at Jagiellonian University (www.jcet.eu). He graduated with honours in Medicine (1990), obtained his PhD in Medicine (1993 summa cum laude) and research training in the Chair of Pharmacology headed by Prof. Richard Gryglewski. He received fellowship in Strathclyde University, UK (Prof. J. Parratt, 1993), Post Ph.D. fellowship in the Arhus University, Denmark (Prof. M. Mulvany 1994-1995), and NIH fellowship in the BWH, Harvard Medical School, Boston, USA (Prof. E. J. Neer, 1997) at finally become a full professor at Jagiellonian University in Kraków (2006). His major research interests include pathophysiology biochemistry and pharmacology of endothelium, role of endothelial mediators in vascular inflammation, pharmacology of platelets. His scientific activity includes over 310 publications; including 240 peer-reviewed original publications, 34 reviews, 27 editorials, 12 book chapters. He is also an author or co-author of 81 patent applications and 46 granted patents (12 patent families).
Is isobolography relevant in the treatment strategy of drug-resistant epilepsy?
Prof. Stanisław Czuczwar
Medical University of Lublin, Poland;
Vice-President of the Polish Academy of Sciences, Poland
- Born in Lublin on May 7th, 1952
- Graduated from Medical University of Lublin in 1975
- Member of the Polish Pharmacological Society since 1977
- Doctor’s degree in 1979
- Full professor in 1992
- President of the Polish Pharmacological Society – 2007-2010
Corresponding member of the Polish Academy of Sciences (PAS) since 2012 and vice-president of PAS since 2015. At present: head of Department of Pathophysiology of Medical University of Lublin. He is mainly involved in research on interactions between antiepileptic drugs in order to improve the treatment of drug-resistant epilepsy. He has published 421 papers, cited 9834 times, with H index = 48 (according to Scopus, May 10th, 2019). Up till present, he has supervised 44 doctoral theses.
EPHAR LECTURE: Using zebrafish forward genetic screens to identify genes and pathways affecting human behaviour
Caroline Brennan did her PhD at King’s College London in the Lab of Prof J.M. Littleton working on adaptive mechanisms underlying drug dependence. She undertook post-doc training at the Clinical Research Centre Harrow, UK before joining the laboratory of Prof Nigel Holder at The Randall Institute, KCL and moving with him to UCL in 1998. Whilst at KCL and UCL she used zebrafish as a genetic model system for analysis of mechanisms underlying development.
Since 2000 Caroline Brennan has been a Lecturer in Molecular Genetics in the School of Biological Sciences QMUL. In her work she combines the two areas of her expertise: 1) molecular mechanisms underlying drug dependence and 2) zebrafish as a developmental genetic model system. Caroline’s team has developed behavioural assays of drug seeking, compulsive drug seeking and relapse in zebrafish and is using lines of mutant fish to explore the genetics contributing to these behaviours.
Professor Waldemar Janiec, MD, PhD
Medical University of Silesia, Sosnowiec, Poland
Professor Waldemar Janiec, MD, PhD, after finishing his studies at the Silesian Medical Academy (currently Medical University of Silesia) started working in the Department of Pharmacology of the Silesian Medical Academy and conducted research on the participation of cyclic 3’5′-AMP in the mechanism of action of drugs on the functioning of the vegetative system and defining molecular mechanisms of stimulation synthesis melatonin by norepinephrine in the pituitary gland, and the effect of beta-blockers on the activity of phenyl-N-methyltransferases and introduced studies defining the effects of drugs on the skeletal system, especially in experimental osteoporosis. As the secretary of the Polish Pharmacopoeia Commission, he participated in the development of the V-IX edition of the Polish Pharmacopoeia and also took an active part in adapting Polish Pharmacopoeia monograph to the EU Pharmacopoeia. He was chairman of the Medicines Commission and then chairman of the Committee for Registration of Medicines and Medical Materials of the Ministry of Health and Welfare. He prepared four editions of the textbook „Pharmacodynamics” and four editions of the „Compendium of Pharmacology” and published an interesting book “Orphan Drugs in Prosperity and Misery”.